The comparative safety of first-line conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) used for the treatment of rheumatoid arthritis: protocol for a multi-database real-world cohort study

30/01/2020
30/01/2020
EU PAS number:
EUPAS33214
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data source(s)

Data source(s), other

THIN, SIDIAP

Data sources (types)

Administrative healthcare records (e.g., claims)
Drug dispensing/prescription data
Electronic healthcare records (EHR)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No